Frontiers | Cytokines, and biomarkers involved in the immunomodulation of pediatric cancers

Cytokines, and biomarkers involved in the immunomodulation of pediatric cancers

1,461
Total downloads
5,225
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 26 Apr 2024

Transition to a mesenchymal state in neuroblastoma may be characterized by a high expression of GD2 and by the acquisition of immune escape from NK cells

Sabina Di Matteo
Maria Teresa Bilotta
Andrea Pelosi
Dorothee Haas
Tobias Theinert
Gerrit Weber
Paul-Gerhardt Schlegel
Matthias Berg
Lorenzo Moretta
4 more
Ignazio Caruana

Transition to a mesenchymal state in neuroblastoma may be characterized by a high expression of GD2 and by the acquisition of immune escape from NK cells

doi 10.3389/fimmu.2024.1382931

1,604 views
1 citation

REVIEW

Published on 14 Feb 2024

Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target

Marsha Pellegrino
Valerio Secli
Silvia D’Amico
Lucia Lisa Petrilli
Matteo Caforio
Valentina Folgiero
Nicola Tumino
Paola Vacca
Maria Vinci
1 more
Emmanuel de Billy

Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target

doi 10.3389/fimmu.2024.1356321

2,326 views
6 citations

Share on

Frontiers in Immunology

Frontiers in Immunology

Cytokines and Soluble Mediators in Immunity

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

5,225Topic views
3,270Article views
1,461Article downloads